wehewehe
ʻO Vorolazan Intermediate kahi mea koʻikoʻi i ka synthesis o Vorolazan, kahi mea hoʻokūkū ikaika a koho i ka potassium-competitive acid blocker i hoʻohana ʻia e mālama i ka maʻi gastroesophageal reflux (GERD) a me nā maʻi e pili ana i ka waikawa.He mea koʻikoʻi kēia pūhui waena i ka hana ʻana o Vorolazan a he mea nui ia i ka ʻoihana lāʻau.
Loaʻa i nā kikowaena Vorolazan ka hoʻomaʻemaʻe kiʻekiʻe a me ka hoʻolālā kemika pololei, i kūpono iā lākou no ka R&D a me ka hana nui.Loaʻa kā mākou huahana i nā ana mana koʻikoʻi e hōʻoia i ko lākou kūpaʻa a me ka hilinaʻi, e hoʻolilo iā lākou i mea kūpono no nā mea hana lāʻau lapaʻau a me nā mea noiʻi.
He waiwai nui kēia pūhui i ka ʻoihana lāʻau lapaʻau no ka mea he kuleana nui ia i ka synthesis o Vorolazan, kahi lāʻau holomua no ka mālama ʻana i nā maʻi pili i ka waikawa.Ke hoʻomau nei ʻo Vorolazan i ka hoʻomaopopo ʻana no kona pono i ka mālama ʻana i ka maʻi reflux gastroesophageal a me nā kūlana e pili ana, ke piʻi nei ka noi no Vorolazan intermediates.
E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.